Literature DB >> 17027546

Ten-year results of ALIZE acetabular cup with hydroxyapatite coating and AURA hydroxyapatite-coated stem in total hip arthroplasty.

Jean-Philippe Fayard1, François Chalencon, Jean-Paul Passot, Laurent Dupre Latour, Grégoire Edorh.   

Abstract

One hundred seven total hip arthroplasties were done between 1991 and 1992 with ALIZE acetabular cup with hydroxyapatite coating (Biomet France, Valence, France) and AURA hydroxyapatite-coated stem (Biomet France) in 107 patients. The articulation was ceramic on polyethylene for 102 patients and metal on polyethylene for the remaining 5 patients. The mean follow-up of the series was 8.4 +/- 2.5 years. The mean preoperative Merle d'Aubigné hip functional score was 10.6 +/- 3 vs 15.8 +/- 1.8 at the latest follow-up. Sixty-three patients were alive for the long-term follow-up at a mean of 9.67 +/- 0.25 years. Of the patients, 98.5% were satisfied or very satisfied at the latest follow-up. Five revisions were documented in these series: 1 for acetabular loosening, 2 for traumatic ceramic head fracture, 1 for polyethylene replacement, and 1 for stem replacement due to bone fracture. The mean wear rate was 0.076 +/- 0.043 mm/y (<0.1 mm/y considered as the normal wear rate). The overall survival rate at 10 years was 95.6% +/- 2.1% using revision of either component as the end point.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027546     DOI: 10.1016/j.arth.2005.10.025

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  2 in total

Review 1.  Fracture of ceramic bearing surfaces following total hip replacement: a systematic review.

Authors:  Francesco Traina; Marcello De Fine; Alberto Di Martino; Cesare Faldini
Journal:  Biomed Res Int       Date:  2013-06-13       Impact factor: 3.411

2.  Long-term durability of alumina ceramic heads in THA.

Authors:  Nicholas A Beckmann; Tobias Gotterbarm; Moritz M Innmann; Christian Merle; Thomas Bruckner; J Philippe Kretzer; Marcus R Streit
Journal:  BMC Musculoskelet Disord       Date:  2015-09-12       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.